RheumaGen was named Colorado’s Most Innovative Emerging Company of 2023 after presenting at the Colorado BioScience Association’s Innovation Showcase on October 2, 2023. RheumaGen was selected as a finalist to present, along with illumifyDx and TissueForm, Inc., and was awarded the top prize in honor of its innovative approach to HLA gene editing to treat autoimmune diseases.
Learn more here.
Media inquiries: RheumaGen@argotpartners.com
Please be aware of scams that impersonate RheumaGen recruiters. All official communications from RheumaGen will come from a rheumagen.com email address, and we will never ask for sensitive personal or financial information from candidates.
RheumaGen was founded to relieve the burden that individuals suffering from autoimmune diseases have carried for so long. Mindful also of our own family members who are patients, we are not interested in incremental improvements. We seek cures; we seek remission.